Market News AIOpen the app

HSDT stock news · Solana Company

Stories about Solana Company (HSDT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for HSDT

Follow Solana Company (HSDT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HSDT
Free on the App Store and Google Play, or on the web.
  1. Oct 7, 2026, 5:54 AM ET · New boss

    The CEO of Solana says China is paying close attention to cryptocurrency and can't overlook it.

    Neutral

    Solana Company’s CEO said China is studying crypto closely, but mainland trading and mining remain banned. The comments report no policy change or direct benefit for the company.

  2. Oct 7, 2026, 5:53 AM ET · New boss

    The CEO of Solana says China is paying close attention to cryptocurrency and can't overlook it.

    Neutral

    Solana Company’s chief says China is studying crypto, but China still bans trading and mining. The story reports no policy change or new business for Solana Company.

  3. Sep 30, 2026, 5:33 PM ET · Market

    Solana Co says it plans to sell about 4.37 million shares to raise around $15 million.

    Bad for HSDT

    Solana Co arranged to raise about $14.3 million after fees through shares and warrants. The cash may help its plans, but added shares could shrink each existing share's slice.

  4. Sep 18, 2026, 2:27 PM ET · Market

    On Friday, 12 health care stocks changed a lot in price, with IM Cannabis jumping 246%.

    Good for HSDT

    Solana stock moved up 18.34% to $2.71. The price rise reflects positive trading sentiment for the company's shares today.

  5. Aug 14, 2026, 5:43 PM ET · Results

    Complete Record: Helius Medical Tech's Earnings Call for Q2 2026

    Neutral

    Helius Medical Tech's Q2 2026 earnings call revealed a substantial increase in revenue and a strategic shift towards digital assets, which could enhance shareholder value and market positioning. The company's focus on expanding its validator infrastructure in the Asia-Pacific region and ongoing share repurchases further supports a bullish outlook.